secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSULET CORP (PODD)
CIK:        0001145197
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001145197-26-000081
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insulet voluntarily corrects Omnipod 5 pods; 18 serious adverse events, up to $40M cost
--------------------------------------------------------------------------------

- Voluntary medical device correction for specific lots of Omnipod 5 Pods due to small tear in internal tubing causing under-delivery of insulin.
- Insulet received 18 reports of serious adverse events including hospitalization and DKA; no deaths reported.
- Affected pods represent approximately 1.5% of annual Omnipod 5 production; other products unaffected.
- Insulet expects up to $40 million in correction costs in 2026, excluded from adjusted results; 2026 guidance unchanged.
- Insulet implemented manufacturing process updates and notified FDA; customers can check lot numbers and get free replacements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145197/000114519726000081/0001145197-26-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145197/000114519726000081/podd-20260312.htm
  HTML page:      https://secwatch.observer/filing/0001145197-26-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer